Denis Anthony Mitchison

Denis Anthony Mitchison's AcademicInfluence.com Rankings

Philosophy

#3723

World Rank

#5963

Historical Rank

Logic

#1358

World Rank

#2089

Historical Rank

philosophy Degrees

Denis Anthony Mitchison

Biology

#4700

World Rank

#6986

Historical Rank

Microbiology

#165

World Rank

#195

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Denis Anthony Mitchison Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Denis Anthony Mitchison's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. (1969) (839)
The curious characteristics of pyrazinamide: a review. (2003) (610)
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. (1963) (565)
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. (1999) (544)
The action of antituberculosis drugs in short-course chemotherapy. (1985) (507)
The early bactericidal activity of drugs in patients with pulmonary tuberculosis. (2015) (488)
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. (2015) (390)
Role of individual drugs in the chemotherapy of tuberculosis. (2000) (334)
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. (2003) (330)
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. (1998) (319)
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. (2008) (311)
Basic mechanisms of chemotherapy. (1979) (277)
Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. (1993) (222)
Streptomycin Resistance in Pulmonary Tuberculosis (1948) (218)
Mechanisms of Pyrazinamide Action and Resistance. (2014) (211)
Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis (2003) (203)
CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI (1988) (191)
The diagnosis and therapy of tuberculosis during the past 100 years. (2005) (186)
Detection of mRNA Transcripts and Active Transcription in Persistent Mycobacterium tuberculosisInduced by Exposure to Rifampin or Pyrazinamide (2000) (182)
Quality control in tuberculosis bacteriology. 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination. (1980) (171)
ANTIGENIC DIVERSITY OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS DETECTED BY MEANS OF MONOCLONAL ANTIBODIES (1981) (158)
The chemotherapy of tuberculosis: past, present and future. (2012) (150)
Drug resistance in mycobacteria. (1984) (135)
Short-course chemotherapy for pulmonary tuberculosis. (1975) (130)
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. (1997) (129)
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. (1981) (124)
A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. (1960) (118)
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. (1999) (117)
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. (2000) (117)
Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. (1998) (113)
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis. (2005) (109)
Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. (1993) (102)
An effective method of RNA extraction from bacteria refractory to disruption, including mycobacteria. (1997) (101)
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo (2015) (98)
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis (1996) (92)
Understanding the chemotherapy of tuberculosis—current problems (1992) (92)
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment. (1993) (92)
Timing of relapse in short-course chemotherapy trials for tuberculosis. (2010) (91)
Bactericidal Action of Gatifloxacin, Rifampin, and Isoniazid on Logarithmic- and Stationary-Phase Cultures of Mycobacterium tuberculosis (2005) (90)
The use of murine monoclonal antibodies without purification of antigen in the serodiagnosis of tuberculosis. (1982) (90)
VIRULENCE IN THE GUINEA-PIG, SUSCEPTIBILITY TO HYDROGEN PEROXIDE, AND CATALASE ACTIVITY OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN AND BRITISH PATIENTS. (1963) (90)
The search for new sterilizing anti-tuberculosis drugs. (2004) (89)
Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis. (2006) (87)
A selective oleic acid albumin agar medium for tubercle bacilli. (1972) (85)
Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis. (2015) (83)
Sulphadimidine Acetylation Test for Classification of Patients as Slow or Rapid Inactivators of Isoniazid (1970) (79)
Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis (2001) (78)
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report. (1998) (77)
The prevalence of drug-resistant tubercle bacilli in untreated patients with pulmonary tuberculosis; a national survey, 1955-56. (1957) (73)
The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. (1995) (72)
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria. (1987) (69)
The chemotherapy of tuberculosis: past, present and future [State of the art]. (2012) (68)
FALSE-POSITIVE ACID-FAST SMEARS (1975) (67)
The near future: improving the activity of rifamycins and pyrazinamide. (2010) (67)
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis. (1997) (67)
THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS. (1964) (64)
Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis. (1968) (64)
Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide (1996) (64)
Suitability of rifampicin for intermittent administration in the treatment of tuberculosis. (1970) (64)
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. (1992) (64)
Tubercle Bacilli Resistant to Isoniazid (1954) (63)
In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosis (1966) (63)
In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis. (1987) (60)
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. (1996) (60)
Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium (2004) (60)
Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens. (2004) (58)
Metronidazole has no antibacterial effect in Cornell model murine tuberculosis. (1998) (57)
Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis. (2008) (57)
Drug resistance in tuberculosis (2005) (57)
Amikacin in the treatment of pulmonary tuberculosis. (1983) (55)
Examination of smears for tubercle bacilli by fluorescence microscopy. (1959) (53)
Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. (2014) (53)
Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs. (2004) (51)
Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells. (2010) (51)
Development of Streptomycin Resistant Strains of Tubercle Bacilli in Pulmonary Tuberculosis (1950) (50)
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. (2002) (50)
Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice. (1953) (49)
Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages. (1992) (49)
Laboratory aspects of intermittent drug therapy (1971) (48)
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test. (1961) (48)
The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea-pig virulence and in vitro-indicators of virulence. (1978) (47)
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems. (1992) (47)
The bactericidal activities of antituberculous drugs. (1956) (46)
Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis. (1970) (45)
Bactericidal Activity of Streptomycin and Isoniazid Against Tubercle Bacilli (1954) (44)
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 2. Comparison with virulence of tubercle bacilli from British patients. (1961) (44)
The hepatic toxicity of isoniazid among rapid and slow acetylators of the drug. (1978) (42)
Pyrazinamide and other drugs in tuberculous meningitis. (1973) (42)
Comparison of strains of Mycobacterium tuberculosis from British, Ugandan and Asian immigrant patients: a study in bacteriophage typing, susceptibility to hydrogen peroxide and sensitivity to thiophen-2-carbonic acid hydrazide. (1977) (42)
Effects of Four Different Meal Types on the Population Pharmacokinetics of Single-Dose Rifapentine in Healthy Male Volunteers (2010) (40)
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. (2016) (40)
The early bactericidal activity of amikacin in pulmonary tuberculosis. (2001) (40)
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol. (1976) (40)
Mechanisms of Pyrazinamide Action and Resistance. (2014) (38)
Treatment of Tuberculosis (1980) (38)
Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis (2000) (38)
A method of estimating streptomycin in serum and other body fluids by diffusion through agar enclosed in glass tubes. (1949) (38)
Sources of variation in studies of the early bactericidal activity of antituberculosis drugs. (2001) (37)
Assessment of the Efficacy of New Anti-Tuberculosis Drugs. (2009) (36)
The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis. (2001) (36)
Selective Kirchner medium in the culture of specimens other than sputum for mycobacteria. (1983) (36)
Quality control in tuberculosis bacteriology. 2. The origin of isolated positive cultures from the sputum of patients in four studies of short course chemotherapy in Africa. (1980) (36)
Serodiagnosis of tuberculosis using an ELISA with antigen 5 and a hemagglutination assay with glycolipid antigens. Results in patients with newly diagnosed pulmonary tuberculosis ranging in extent of disease from minimal to extensive. (1990) (35)
Moxifloxacin and Gatifloxacin in an Acid Model of Persistent Mycobacterium tuberculosis (2006) (34)
The early bactericidal activity of streptomycin. (2002) (34)
Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis. (1982) (33)
Assay of rifampicin in serum (1974) (33)
The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment services. (1970) (33)
The activity of low-clearance liposomal amikacin in experimental murine tuberculosis. (2001) (33)
Community-based short-course treatment of pulmonary tuberculosis in a developing nation. (1992) (33)
Tuberculosis Diagnosis and Multidrug Resistance Testing by Direct Sputum Culture in Selective Broth without Decontamination or Centrifugation (2008) (33)
Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease. (1996) (32)
New antibacterial drugs for the treatment of mycobacterial disease in man. (1988) (32)
Experimental models of tuberculosis: can we trust the mouse? (2009) (31)
Bacteriology of Tuberculosis (1974) (31)
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase. (2000) (31)
Primary drug resistance in pulmonary tuberculosis in Great Britain: second national survey, 1963. (1966) (31)
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial (2016) (30)
Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling. (2010) (30)
Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone. (1961) (30)
Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis. (1986) (29)
Counts of viable tubercle bacilli in sputum related to smear and culture gradings. (1992) (29)
SHORT-COURSE CHEMOTHERAPY FOR TUBERCULOSIS (1976) (28)
The susceptibility to hydrogen peroxide of Indian and British isoniazid-sensitive and isoniazid-resistant tubercle bacilli (1960) (28)
Prevention of Colds by Vaccination against a Rhinovirus (1965) (28)
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy. (1961) (28)
Geographic distribution of bacteriophage types of Mycobacterium tuberculosis. (1969) (28)
Pharmacology of some slow-release preparations of isoniazid of potential use in intermittent treatment of tuberculosis. (1972) (28)
Isoniazid activity is terminated by bacterial persistence. (2007) (27)
[Mechanisms of the action of drugs in the short-course chemotherapy]. (1985) (27)
Development of rifapentine: the way ahead. (1998) (27)
Prevention of drug resistance by combined drug treatment of tuberculosis. (2012) (27)
Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis. (1992) (27)
Short-term intermittent chemotherapy of experimental tuberculosis in the guinea pig (1966) (26)
THE TUBERCLE BACILLUS (1959) (26)
VIRULENCE IN THE GUINEA-PIG AND SUSCEPTIBLITY TO HYDROGEN PEROXIDE OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS. (1964) (26)
Shortening the treatment of tuberculosis (2005) (25)
Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide. (1966) (25)
Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various meals. (1994) (25)
Bacteriological aspects of a survey of the incidence of drug-resistant tubercle bacilli among untreated patients. (1957) (25)
Effect of vaccines in a murine model of dormant tuberculosis. (1994) (25)
Isoniazid-resistant strains of tubercle bacili; their development and stability. (1953) (24)
The segregation of streptomycin-resistant variants of Mycobacterium tuberculosis into groups with characteristic levels of resistance. (1951) (24)
Atypical mycobacteria and drug-resistant tubercle bacilli isolated during a survey of untreated patients with pulmonary tuberculosis. (1959) (24)
In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis. (1987) (24)
Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254 (1989) (23)
Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy. [Corrected]. (2015) (23)
INFLUENCE OF PRETREATMENT BACTERIAL RESISTANCE TO ISONIAZID, THIACETAZONE OR PAS ON THE RESPONSE TO CHEMOTHERAPY OF AFRICAN PATIENTS WITH PULMONARY TUBERCULOSIS. (1963) (23)
Selective media in the isolation of tubercle bacilli from tissues (1973) (22)
Basic Concepts in the Chemotherapy of Tuberculosis (1998) (22)
Effect of pyridoxine on vitamin B6 concentrations and glutamic-oxaloacetic transaminase activity in whole blood of tuberculous patients receiving high-dosage isoniazid. (1967) (22)
Pyrazinamide — on the antituberculosis drug frontline (1996) (21)
The contribution of hydrogen peroxide resistance to virulence of Mycobacterium tuberculosis during the first six days after intravenous infection of normal and BCG-vaccinated guinea-pigs. (1981) (21)
Hemagglutination tests for tuberculosis with mycobacterial glycolipid antigens. Results in patients with active pulmonary tuberculosis before and during chemotherapy and in healthy tuberculosis contacts. (1981) (20)
Monocyte antimycobacterial activity before and after Mycobacterium bovis BCG vaccination in Chingleput, India, and London, United Kingdom (1993) (20)
HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. (1988) (20)
Clinical development of anti-tuberculosis drugs. (2006) (20)
Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance. (1969) (19)
VIRULENCE IN THE GUINEA-PIG AND SENSITIVITY TO PAS AND THIACETAZONE OF TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS WITH PULMONARY TUBERCULOSIS. (1964) (19)
Cumulative effects of pulsed exposures of mycobacterium tuberculosis to isoniazid. (1973) (19)
In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens. (1968) (19)
THE VIRULENCE IN THE GUINEA-PIG OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN HONG KONG. (1963) (19)
Experimental infective pneumoconiosis. (1953) (19)
Infectivity of patients with pulmonary tuberculosis during chemotherapy. (1990) (19)
Optimizing Outpatient Serial Sputum Colony Counting for Studies of Tuberculosis Treatment in Resource-Poor Settings (2012) (19)
Biomarkers for tuberculosis disease activity, cure, and relapse. (2010) (19)
Bioavailability of rifampin in experimental murine tuberculosis (1992) (19)
Serum rifampicin concentration related to dose size and to the incidence of the 'flu' syndrome during intermittent rifampicin administration. (1977) (18)
Evaluation of a serological test for tuberculosis. (1977) (18)
Letter: False-positive acid-fast smears. (1975) (18)
Controlled double-blind study of the effect of rifampin on humoral and cellular immune responses in patients with pulmonary tuberculosis and in tuberculosis contacts. (1980) (18)
Examination of operation specimens from patients with spinal tuberculosis for tubercle bacilli. (1983) (18)
THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES. (1964) (18)
Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins. (2012) (18)
Demonstration of increased anti-mycobacterial activity in peripheral blood monocytes after BCG vaccination in British school children. (1988) (17)
The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis. (1972) (17)
Viable counting of Mycobacterium tuberculosis in a silica gel medium. (1957) (17)
A computer-assisted bacteriology reporting and information system. (1978) (17)
Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. (1997) (17)
Experimental infective pneumoconiosis. IV. Massive pulmonary fibrosis produced by coal-mine dust and isoniazid-resistant tubercle bacilli of low virulence. (1955) (17)
Mechanisms of Tuberculosis Chemotherapy (1997) (16)
Split‐drug regimens for the treatment of patients with sputum smear‐positive pulmonary tuberculosis – a unique approach (2004) (16)
COMPARISON OF THE SENSITIVITY TO THIACETAZONE OF TUBERCLE BACILLI FROM PATIENTS IN BRITAIN, EAST AFRICA, SOUTH INDIA AND HONG KONG. (1964) (16)
Detection of rifampicin in urine by a simple microbiological assay. (1970) (15)
Bactericidal Activity of Moxifloxacin on Exponential and Stationary Phase Cultures of Mycobacterium tuberculosis (2009) (15)
In vitro activities against mycobacteria of two long-acting rifamycins, FCE22807 and CGP40/469A (SPA-S-565). (1990) (15)
The pattern of mycobacterial antigen recognition in sera from Mantoux‐negative individuals is essentially unaffected by bacilli Calmette‐Guérin (BCG) vaccination in either South India or London (1992) (15)
Problems of drug resistance. (1954) (15)
Serum concentrations and antituberculosis activity of thiacetazone. (1974) (15)
The 45 kilodalton molecule of Mycobacterium tuberculosis identified by immunoblotting and monoclonal antibodies as antigenic in patients with tuberculosis. (1989) (15)
Slide culture sensitivity tests. (1989) (15)
Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility. (2009) (15)
Effects of recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin on infections of mouse peritoneal macrophages with Listeria monocytogenes and Mycobacterium microti in vitro. (1986) (14)
The prevalence of bacterial resistance to isoniazid and to PAS in patients with acute pulmonary tuberculosis presenting for treatment in East Africa. (1960) (14)
Tuberculosis in patients having dialysis. (1980) (14)
Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig. (1989) (13)
Bactericidal activity of streptomycin and isoniazid in combination with p-aminosalicylic acid against Mycobacterium tuberculosis. (1955) (13)
Intermittent Dosage in the Treatment of Pulmonary Tuberculosis with Streptomycin (1950) (13)
Culture of specimens other than sputum for Mycobacteria (1974) (13)
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic target. (2015) (13)
Contradictory Results with High-Dosage Rifamycin in Mice and Humans (2013) (12)
Evaluation of New Antituberculosis Drugs in Mouse Models (2007) (12)
Pyrazinamide in the chemoprophylaxis of tuberculosis. (1990) (12)
Chemotherapy of Tuberculosis: a Bacteriologist's Viewpoint* (1965) (12)
Studies on the treatment of experimental tuberculosis of the guinea pig with intermittent doses of isoniazid. (1973) (12)
The occurrence of independent mutations to different types of streptomycin resistance in Bacterium coli. (1953) (11)
Examination of sputum by smear and culture in case-finding. (1968) (11)
[The detection of isoniazid in urine]. (1958) (11)
A comparison of various measures of sensitivity of M. tuberculosis to pyrazinamide. (1970) (11)
Tests for streptomycin sensitivity of tubercle bacilli in tween 80 albumin liquid medium. (1949) (11)
Standard smears for grading the content of acid-fast bacilli in sputum. (1966) (11)
A vertical diffusion method for the microbiological assay of isoniazid (1964) (10)
The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis. (1955) (10)
Comparative value of sputum smear examination and culture examination in assessing the progress of tuberculous patients receiving chemotherapy. (1966) (10)
Early bactericidal activity and sterilizing activity of ciprofloxacin in pulmonary tuberculosis. (1995) (10)
Comparison of Solid and Liquid Medium Sensitivity Tests of Tubercle Bacilli to para-Aminosalicylic Acid (1955) (10)
A comparison of the sensitivity to p-aminosalicylic acid of tubercle bacilli from South Indian and British patients. (1960) (10)
Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis. (2003) (9)
THE RESPONSE TO TREATMENT WITH THIACETAZONE OF GUINEA-PIGS AND MICE INFECTED WITH TUBERCLE BACILLI OBTAINED FROM UNTREATED AFRICAN PATIENTS. (1963) (9)
Efficacy of intermittent pyrazinamide in experimental murine tuberculosis. (1991) (9)
Comparison of machine and manual staining of direct smears for acid-fast bacilli by fluorescence microscopy. (1976) (9)
Studies of serial plasma Isoniazid concentrations with different doses of a slow-release preparation of Isoniazid. (1975) (9)
Bacteriological aspects of mycobacterial infections. (1972) (8)
Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs. (2011) (8)
Microbial genetics and chemotherapy. (1962) (8)
Experimental infective pneumoconiosis. II. Coal-mine dust with attenuated tubercle bacilli (B.C.G.) in the lungs of immunised guinea-pigs. (1955) (8)
Natural sensitivity of M. tuberculosis to thiacetazone. (1968) (8)
Fluoroquinolones in the treatment of tuberculosis: a study in mice. (2004) (8)
The virulence of South Indian tubercle bacilli in mice and guinea-pigs infected by the intravenous route. (1961) (8)
The Behaviour of Mixtures of Streptomycin-sensitive and -resistant Tubercle Bacilli in Liquid Medium Sensitivity Tests (1950) (8)
Bacteriological aspects of the second national survey of primary drug resistance in pulmonary tuberculosis, 1963. (1966) (8)
PROBENECID AND SERUM-RIFAMPICIN (1975) (7)
Reappraisal of the activity of morphazinamide against M. tuberculosis. (1975) (7)
Experimental infective pneumoconiosis. V. Massive fibrosis of the lungs produced by coal-mine dust and Mycobacterium tuberculosis var. muris (Vole bacillus). (1957) (7)
DNA analysis demonstrates that mycococcus forms are not mycobacteria. (1993) (6)
Chapter 5: Recent Developments in the Study of Pyrazinamide: An Update (2011) (6)
The Psychiatrist, His Training and Development (1954) (6)
Experimental infective pneumoconiosis. III. Coal-mine dust and isoniazid-resistant tubercle bacilli of moderate virulence. (1955) (5)
Comparison of Techniques for Measuring the Isoniazid Resistance of Tubercle Bacilli (1953) (5)
Use of the Phoenix system for bacteriology (1983) (5)
A new antituberculosis drug that selectively kills nonmultiplying Mycobacterium tuberculosis. (2008) (5)
Virulence of isoniazid-resistant tubercle bacilli. (1954) (5)
Rifabutin in the treatment of newly diagnosed pulmonary tuberculosis. (1995) (5)
The relationship between nicotinamide adenine dinucleotide concentration and antibacterial activity of isoniazid in Mycobacterium tuberculosis. (1977) (5)
The control of tuberculosis: progress & prospect. (2005) (4)
Activity of the combination of fludalanine and cycloserine against mycobacteria in vitro. (1985) (4)
Solid and liquid medium tests of streptomycin sensitivity of Mycobacterium tuberculosis. (1958) (4)
Turning intermittent regimens into daily regimens using blister-packs. An exploration in murine tuberculosis. (1993) (4)
Organization of tuberculosis laboratory services in developing countries. (1982) (4)
The virulence in the guinea-pig of isoniazid-sensitive tubercle bacilli isolated from South Indian patients before treatment and after three months of chemotherapy. (1961) (4)
THE EPIDEMIOLOGY OF TUBERCLE BACILLI. (1963) (4)
Errors in the Estimation of Streptomycin in Serum (1949) (3)
Gamma interferon in experimental murine tuberculosis. (1988) (3)
Tuberculosis hits back (2004) (3)
The consistency of the virulence in the guinea-pig of tubercle bacilli isolated on different occasions from South India patients before treatment (1961) (3)
The sensitivity to thiacetazone and para-aminosalicylic acid and the virulence in the guinea pig of East African strains of Mycobacterium tuberculosis. (1969) (3)
TUBERCULOSIS IN THE THIRD WORLD. REPLY (1992) (3)
Activity of Pyrazinamide in the Guinea Pig Model of Tuberculosis (2010) (3)
[The role of sensitivity tests in short-term chemotherapy]. (1983) (2)
A comparison of various measures of sensitivity of M. tubercolosis to pyrazinamide. (1970) (2)
A case of pulmonary tuberculosis due to isoniazid-resistant, guinea-pig attenuated, Myco. tuberculosis. (1957) (2)
A reiterative method for calculating bactericidal activity. (2003) (2)
Bacteriological mechanisms in recent controlled chemotherapy studies. (1970) (2)
Experimental investigations of bacteriological mechanisms in short course chemotherapy. (1976) (2)
Nicotine and Mycobacteria (1983) (2)
In vitro and animal experiments with rifampicin (1969) (1)
[The chemotherapy of tuberculosis]. (1984) (1)
SHORT-COURSE CHEMOTHERAPY OF TUBERCULOSIS (1976) (1)
Bacterial and Mycotic Infections of Man (2015) (1)
Tuberculosis in the Third World. (1992) (1)
Sensitive microbiological method for the detection of rifampicin in urine. (1974) (1)
The addition of para-aminobenzoic acid or catalase to Löwenstein-Jensen medium and the effect of prolonged incubation in the culture of tubercle bacilli (1960) (1)
What is drug resistance? (1969) (1)
The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens. (1975) (1)
II. Clinical Applications of Antibiotic and Chemotherapeutic Agents (1971) (1)
Computer-aided procedures in a multi-centre co-operative controlled clinical trial in pulmonary tuberculosis. (1971) (1)
[Organization of laboratory services for tuberculosis in developing countries]. (1982) (1)
[Short term chemotherapy of tuberculosis. Bactericidal mechanisms in short term chemotherapy]. (1978) (1)
Prophylactic chemotherapy. (1957) (1)
SERIES ''CONTROVERSIAL ISSUES IN TUBERCULOSIS'' Edited by A. Torres and J. Caminero Number 3 in this Series Drug resistance in tuberculosis (2005) (1)
Report on Two Species of the Genus Fusiformis obtained from Pathological Lesions in Man (1947) (1)
Estimating drug-dosage regimens. (1969) (1)
Letter: Sensitivity to rifampicin. (1974) (1)
Chemotherapy for the good chronic. (1957) (1)
Discussion on Chemotherapy of Tuberculosis. (1953) (1)
Implications of the Hong Kong Study of policies of sensitivity testing. (1972) (0)
Activity in vitro of Rifabutin, FeE 22807, Rifapentine, and Rifampin against Mycobacterium microti and M. tuberculosis and Their Penetration into (1992) (0)
CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS (1980) (0)
Monoclonal antibodies against Mycobacterium avium/intracellulare. (1988) (0)
Confidential: for peer review only Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs (2010) (0)
Adequacy of 6-month follow-up in chemotherapy trials Reply (2010) (0)
073-PA11 Early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis compared to that of isoniazid (1995) (0)
Letter: Probenecid and serum-rifampicin. (1975) (0)
[Bacteriology and immunology in tuberculosis]. (1983) (0)
Culture media for tubercle bacilli during chemotherapy with isoniazid. (1954) (0)
PYRAZINAMIDE IN THE CHEMOPROPHYLAXIS OF TUBERCULOSIS. COMMENT. AUTHORS' REPLY (1990) (0)
Comparative Value of SputumSmear Examination and Culture Examinationin Assessing the Progress of TuberculousPatients Receiving Chemotherapy (1966) (0)
Short-course chemotherapy for pulmonary tuberculosis. (1975) (0)
The Susceptibility to Hydrogen Peroxideof Indian and British Isoniazid-Sensitiveand Isoniazid- Resistant Tubercle Bacilli (1960) (0)
The present position of paraamino-salicylic acid. (1948) (0)
BCG vaccination in South India does not enhance antimycobacterial activity in peripheral blood monocytes - direct contrast with results in Britain (1989) (0)
Tuberculosis in patients having dialysis. (1980) (0)
Regional variation in the guinea-pig virulence and other characteristics of tubercle bacilli (2005) (0)
Symposium on drug resistant tuberculosis. Reserve drug combinations. (1970) (0)
Streptomycin, the present position. (1948) (0)
Diary of the Week (1984) (0)
Rifampicin-containing chemoprophylaxis regimens compared in cornell model murine tuberculosis (1994) (0)
The early bactericidal activity of different dosages of isoniazid (1994) (0)
Avertical diffusion method forthemicrobiological assayofisoniazid (1964) (0)
Culture ofspecimens other thansputum for Mycobacteria (1974) (0)
The Infectivity and Pathogenicity of Indian Tubercle Bacilli (1963) (0)
Re-emergence of tuberculosis. (1993) (0)
Isoniazid resistance in vitro and in vivo. (1953) (0)
[Response to the short-course chemotherapy in patients presenting initial resistance]. (1985) (0)
Action of pyrazinamide, isoniazid and rifampicin on M. microti in vitro and in mouse peritoneal macrophages (1994) (0)
Short-Course Chemotherapy for Pulmonary Tuberculosis1, 2 (2015) (0)
Choice of Drugs for Short Course Chemotherapy (1976) (0)
Catalase-enriched medium. (1962) (0)
Susceptibility Tests and Initial and Primary Drug Resistance in Tuberculosis (2015) (0)
Letter: Evidence for infection by two distinct strains of Myobacterium tuberculosis in pulmonary tuberculosis. (1976) (0)
Kingdom.India, and London, United after Mycobacterium bovis BCG vaccination in Monocyte antimycobacterial activity before and (2013) (0)
Addition of catalase to Lowenstein-Jensen medium. (1961) (0)
Dr Kenneth Citron talks with leading British contributors to Tuberculosis research: Professor Denis Mitchison: Interview 2 (2017) (0)
Comparison ofmachine andmanual staining of direct smearsforacid-fast bacilli byfluorescence microscopy (1976) (0)
IN VITRO OBSERVATIONS ON THE SlJlTABlLlTY OF NEW RIFAMYCHUS FOR THE INTERMIlTENT CHEMOTHERAPY OF TUBERCULOSIS (1987) (0)
Comparison of policies of sensitivity testing of tubercle bacilli in Hong Kong. (1972) (0)
Tuberculous infection. (1971) (0)
Correction for Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy. (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Denis Anthony Mitchison?

Denis Anthony Mitchison is affiliated with the following schools:

Denis Anthony Mitchison's Academic­Influence.com Rankings

Why Is Denis Anthony Mitchison Influential?

Denis Anthony Mitchison's Published Works

Published Works

What Schools Are Affiliated With Denis Anthony Mitchison?

Denis Anthony Mitchison's AcademicInfluence.com Rankings